Senior insider sale
General Counsel at ZENTALIS PHARMACEUTICALS, INC. — senior position signals high conviction
$38.2K
3.31K shares
What this filing means
PAUL ANDREA plans to sell 3.31K shares of ZENTALIS PHARMACEUTICALS, INC. valued at approximately $38.2K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/2/2024ACC: 0001725160-24-000023
Officer· General Counsel
Since Aug 2022
3.31K
Shares to sell
$38.2K
Approx. market value
3.31K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Release
NA
2/1/2024
3.31KTotal acquired3.31K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/1/2024 | Restricted Stock Unit Release NA | 3.31K | — |
| Total | 3.31K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.31K
Market value
$38.2K
2/2/2024
Total
Units
3.31K
Value
$38.2K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/2/2024 | 3.31K | $38.2K | NASDAQ | Planned |
| Total | 3.31K | $38.2K | ||